A2780 ovarian cancer cell line was used to investigate the effects of Boric Acid (BA) and Calcium Fructoborate (CaF) on the proteomic profile of cells in terms of apoptotic pathways and DNA damage/repair pathways. Cell viability and toxicity were determined by the MTT method. Cells were treated with BA and CaF according to the MTT results and collected for protein isolation. Protein isolation was performed from the cell line. Peptides from each sample were obtained for bottom-up proteomic analysis and run on a LC–MS/MS (DionexUltimate 3000 RSLCnano system/Easy Spray/Q-Exactive Plus, Thermo Scientific, USA) The LC-MSMS raw data were processed with the MaxQuant software and searched with Andromeda search engine against the human UniProt database. Comparison of groups were visualized through heatmaps that were prepared on the pHeatmap, an R function to draw heatmaps. Enriched pathways were determined through inputting the Uniprot codes of each protein on the online mapping tool path DIP. Protein-protein interaction networks were analysed through the Integrated Interactions Database of University of Toronto. As a result, Calcium fructoborate (CFB) may have elicited a strong biological response by markedly reducing the expression of apoptosis-related proteins in some samples and appears to cause a more pronounced change in the expression of DNA repair-related proteins than boric acid. These changes are mostly in the direction of repression (negative values), suggesting that it could potentially suppress DNA repair pathways. The CaF group was found to be associated with apoptosis and DNA repair pathways.
Background/Objectives: Cannabinoid receptor type 2 (CB2) agonists have attracted attention because of their potential effects on tumor-related cellular processes in different cancer models. In the present study, we investigated the effects of the selective CB2 agonist JWH-133 on prostate cancer cell lines (LNCaP, DU-145, and PC3). Methods: Cell viability was evaluated using the MTT assay, while colony-forming capacity and migration-related responses were assessed by colony formation and wound-healing assays, respectively. In addition, the expression levels of selected cell-cycle- and apoptosis-related genes were analyzed by quantitative real-time PCR. Results: JWH-133 reduced cell viability in a time- and concentration-dependent manner, although the magnitude of this effect differed among prostate cancer cell lines. The compound also reduced colony formation in PC3 and LNCaP cells and decreased wound closure in PC3 cells under the experimental conditions used. Furthermore, JWH-133 altered the expression of several cell-cycle- and apoptosis-related genes in DU-145 and PC3 cells. Conclusions: Overall, these findings suggest that JWH-133 modulates multiple cellular responses in prostate cancer cells in a cell-line-dependent manner. However, additional mechanistic studies are required to clarify the molecular pathways underlying these effects.